These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 4275514)
21. Subpopulations of human T lymphocytes. IV. Quantitation and distribution in patients with mycosis fungoides and Sézary syndrome. Gupta S; Safai B; Good RA Cell Immunol; 1978 Aug; 39(1):18-26. PubMed ID: 308846 [No Abstract] [Full Text] [Related]
22. Evidence for HTLV-I associated with mycosis fungoides and B-cell chronic lymphocytic leukemia. Peterman A; Jerdan M; Staal S; Bender B; Striecher H; Schüpbach J; Resnick L Arch Dermatol; 1986 May; 122(5):568-71. PubMed ID: 2871815 [TBL] [Abstract][Full Text] [Related]
23. Anti-Ia-reactive cells in mycosis fungoides: a study of skin biopsies, single epidermal cells and circulating T lymphocytes. Tjernlund UM; Scheynius A; Kabelitz D; Klareskog L Acta Derm Venereol; 1981; 61(4):291-301. PubMed ID: 6173983 [TBL] [Abstract][Full Text] [Related]
24. The immunological profile of mycosis fungoides. Jensen JR; Thestrup-Pedersen K; Ahrons S; Zachariae H Clin Exp Immunol; 1982 Nov; 50(2):397-405. PubMed ID: 6983938 [TBL] [Abstract][Full Text] [Related]
32. Mycosis fungoides. Peripheral T cell subsets defined by specific monoclonal antibodies. Valsecchi R; Reseghetti A; Bontempelli M; Frigeni A; Cainelli T Dermatologica; 1984; 169(1):12-7. PubMed ID: 6236114 [TBL] [Abstract][Full Text] [Related]
33. Letter: Mixed receptors. Dewar AE; Habeshaw JA; Young GA; Stuart AE; Parker AC; Wilson DC Lancet; 1974 Jul; 2(7874):216. PubMed ID: 4135630 [No Abstract] [Full Text] [Related]
34. Transfer factor as an additional therapeutic agent in mycosis fungoides. Zachariae H; Grunnet E; Ellegaard J; Thestrup-Pedersen K Acta Allergol; 1975 Nov; 30(5):272-85. PubMed ID: 1082223 [No Abstract] [Full Text] [Related]
35. Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome. Brouet JC; Flandrin G; Seligmann M N Engl J Med; 1973 Aug; 289(7):341-4. PubMed ID: 4268776 [No Abstract] [Full Text] [Related]
36. [Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)]. Souteyrand P; Thivolet J; Alario A; Schmitt D; Perrot H Dermatologica; 1978; 157(5):268-81. PubMed ID: 150348 [TBL] [Abstract][Full Text] [Related]
37. Letter: T-cells in chronic lymphocytic leukaemia. Kay NE; Douglas SD; Estren S Lancet; 1974 Nov; 2(7892):1326. PubMed ID: 4139571 [No Abstract] [Full Text] [Related]
38. [The T or B nature of neoplastic cells in lymphotic leukemia]. Belpomme D; Dant Chev D; Du Rusquec E; Grandjon D; Huchet R; Pinon F; Pouillart P; Schwarzenberg L; Amiel JL; Mathé G Bull Cancer; 1974; 61(3):387-402. PubMed ID: 4618783 [No Abstract] [Full Text] [Related]
39. Rosette-formation with mouse erythrocytes: VI. T, B, and third population lymphoid cells in mycosis fungoides and effect of leukopheresis. Gupta S; Safai B; Good RA Am J Hematol; 1978; 4(2):133-40. PubMed ID: 150227 [TBL] [Abstract][Full Text] [Related]
40. The role of immunologic aberrations in the pathogenesis of lymphoma; with particular reference to mycosis fungoides and exfoliative erythroderma. Bierman SM Arch Dermatol; 1968 Jun; 97(6):699-711. PubMed ID: 4232349 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]